Left main and multivessel disease

Latest left main and multivessel disease content in interventional cardiology - research, practice, and education

The left main coronary artery provides the primary source of blood flow to the left ventricle. Diseases affecting the left main, by itself or in combination with multivessel disease, place the patient at significant risk for life-threatening cardiovascular events. Treatment requires an understanding of all available tools, devices and techniques, like those employed in invasive imaging and functional assessment, as well as taking into account underlying comorbidities such as diabetes. Advances in imaging techniques, as well as the use of adjunctive pharmacotherapy, vascular access or invasive interventions such as bypass surgery, are important, as are understanding bleeding risks. Use the filters below to access PCRonline resources.

Filtered By
Left main and multivessel disease

371 results

Upper limb subcalvian artery

15 May 2024 – From EuroPCR 2024

This session comprises selected EuroPCR 2024 Clinical Case submissions focused on the upper limb subclavian artery. Attendees will have the opportunity to explore various challenging cases, including complex double bifurcation trouble, successful management of a subclavian arterial aneurysm, saddle thrombus at the vertebro-subclavian junction, and more....

Upper limb subcalvian artery

Complex scenarios beyond complex interventions, time to take multiple factors into account

15 May 2024 – From EuroPCR 2024

Complex scenarios beyond complex interventions, time to take multiple factors into account

Randomised trials: substudies and extended follow-up - A quick update

15 May 2024 – From EuroPCR 2024

This session provides a quick update on various randomised trials, including substudies and extended follow-up data. It covers insights on bifurcation stenting, the symptom-stratified analysis of ORBITA-2, the impact of completeness of revascularisation on clinical outcomes from REVIVED-BCIS2, cost-effectiveness of CABG vs. PCI from FAME 3,...

Randomised trials: substudies and extended follow-up - A quick update

Has the 2023 ESC-EACTS guideline review on left main changed my practice?

15 May 2024 – From EuroPCR 2024

Watch this session if you wish to learn why the 2019 guidelines were revised, how to apply the updated recommendations in clinical settings through case examples, and the criteria for selecting patients with left main stenosis for PCI versus CABG.
The session includes detailed presentations on...

Has the 2023 ESC-EACTS guideline review on left main changed my practice

When imaging guides PCI complications management

15 May 2024 – From EuroPCR 2024

This session features selected EuroPCR 2024 Clinical Case submissions highlighting the role of imaging in managing complications during percutaneous coronary interventions (PCI). Experts will present and discuss cases involving recurrent acute myocardial infarction, stent crumpling, and other unexpected complications, demonstrating how the use of various imaging...

When imaging guides PCI complications management

Make your life easier with imaging during primary PCI for acute coronary syndrome

15 May 2024 – From EuroPCR 2024

This session features selected EuroPCR 2024 Clinical Case submissions highlighting the use of imaging modalities, such as optical coherence tomography (OCT) and intravascular ultrasound (IVUS), during primary percutaneous coronary interventions (PCI) for acute coronary syndrome. Experts will present and discuss challenging cases, demonstrating how the integration...

Make your life easier with imaging during primary PCI for acute coronary syndrome

Hemodynamic support during CTO PCI: to use it or not?

15 May 2024 – From EuroPCR 2024

This session features selected EuroPCR 2024 Clinical Case submissions focused on the use of hemodynamic support devices during percutaneous coronary interventions (PCI) for chronic total occlusions (CTO). Experts will present and discuss challenging cases where the use of devices like the Impella pump or pulsatile left...

Hemodynamic support during CTO PCI: to use it or not?

NSTEMI in patients in post CABG: a challenging combination

15 May 2024 – From EuroPCR 2024

This session focuses on the management of non-ST-elevation myocardial infarction (NSTEMI) in patients who have previously undergone coronary artery bypass grafting (CABG). Attendees will explore various case presentations and discussions on the challenges and treatment strategies for this complex clinical scenario, including the use of intravascular...

NSTEMI in patients in post CABG: a challenging combination

Challenging scenarios in STEMI

14 May 2024 – From EuroPCR 2024

This session features selected clinical case submissions highlighting challenging scenarios in the management of STEMI (ST-Elevation Myocardial Infarction) patients. Participants will learn about complex cases, such as left main time bomb, coronary anomalies, simultaneous two-vessel acute coronary thrombosis, and mechanical complications. The session includes case presentations...

Challenging scenarios in STEMI

Complex PCI in multivessel disease

14 May 2024 – From EuroPCR 2024

This session features selected clinical case submissions focused on complex PCI (Percutaneous Coronary Intervention) in patients with multivessel disease. Participants will learn about various challenging cases, including navigating heart failure, three-vessel disease with functional mitral regurgitation, complete revascularization assisted by Impella, and end-stage refractory angina. The...

Complex PCI in multivessel disease